Advertisement

Topics

The Lustgarten Foundation for Pancreatic Cancer Research Company Profile

09:37 EDT 4th May 2016 | BioPortfolio

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit supporter of pancreatic cancer research, providing more than $20 million to date. The Foundation provides patient information and manages a national public awareness campaign. To learn more and to see Dr. Pausch's PSA, visit www.lustgarten.org.


News Articles [6035 Associated News Articles listed on BioPortfolio]

NGOs join forces in £8 million pancreatic cancer venture

Cancer Research UK, The Lustgarten Foundation, and Stand Up To Cancer have come together in an international collaboration worth £8 million ($12 million) to announce funding for a pancreatic cancer r...

Dream team selected to tackle one of cancer's deadliest forms: Pancreatic cancer

(American Association for Cancer Research) The Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Dream Team of top cancer researchers from the United States and the United Kingdom was named ...

Dream team selected to tackle one of cancer's deadliest forms—pancreatic cancer

The Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Dream Team of top cancer researchers from the United States and the United Kingdom was named here today to launch a fresh attack on panc...

UC San Diego health researchers join pancreatic cancer 'dream team'

(University of California - San Diego) University of California, San Diego School of Medicine researchers Andrew Lowy, MD, and Tannishtha Reya, PhD, have been recruited for their expertise in preclini...

DJ Questlove Performs at 15th Annual Holiday Rock & Roll Bash in Support of the Fight Against Pancreatic Cancer

BETHPAGE, N.Y., Dec. 17, 2015 /PRNewswire/ -- On Wednesday evening, December 16, Cablevision Systems Corporation (NYSE: CVC), The Madison Square Garden Company (NYSE: MSG), and AMC Networks (NASD...

Investigational ABRAXANE Combinations: GI Pancreatic Cancer Research

NewsInvestigational combinations using an ABRAXANE and Gemcitabine Foundation lead ASCO GI pancreatic cancer research.

UK's Pancreatic Cancer Research Fund announces third £1 million funding round

(Pancreatic Cancer Research Fund) Six new research projects are being funded with a total of £1 million by Pancreatic Cancer Research Fund (PCRF) -- the UK's leading pancreatic cancer research charit...

[Seminar] Pancreatic cancer

Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence. Most patients with pancreatic cancer remain asymptomatic until the disease reaches an advanced stage. The...

PubMed Articles [10372 Associated PubMed Articles listed on BioPortfolio]

Triciribine Phosphate Monohydrate, an AKT Inhibitor, Enhances Gemcitabine Activity in Pancreatic Cancer Cells.

Pancreatic cancer is a highly lethal cancer due to early metastasis and resistance to current chemotherapeutic agents. Abnormal protein kinase B (AKT) activation is an important mechanism of chemoresi...

The advances of Midkine with peripheral invasion in pancreatic cancer.

Pancreatic cancer is a deadly malignancy associated with rapid progression and poor prognosis. Perineural invasion (PNI) in pancreatic cancer is one of the most common characteristics of this disease,...

Early detection of pancreatic cancer.

Pancreatic adenocarcinoma is a low-incident but highly mortal disease. It accounts for only 3% of estimated new cancer cases each year but is currently the fourth common cause of cancer mortality. By ...

Role of the tumor microenvironment in pancreatic adenocarcinoma.

Pancreatic cancer is a devastating disease with proclivity for early metastasis, which accounts for its poor prognosis. The clinical problem of pancreatic cancer is its resistance to conventional ther...

Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer.

There is no reliable screening tool to identify people with high risk of developing pancreatic cancer even though pancreatic cancer represents the fifth-leading cause of cancer-related death in Korea....

Clinical Trials [5878 Associated Clinical Trials listed on BioPortfolio]

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

This is a single-centre, prospective, non-randomised research study. The research team will investigate the feasibility of assessing primary human pancreatic tissue for changes to T lympho...

Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

The purpose of this research study is to try to define the highest doses of temsirolimus and gemcitabine that can be used safely in combination to treat advanced pancreatic cancer. Gemcita...

K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability

This study is an open and single-center Phase I clinical research on patients with advanced pancreatic cancer, for evaluating their adverse reactions or tolerance to K-001, so as to determ...

A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health fa...

Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.

This no treatment research study is being done to find a safe and an appropriate dose of antibody (protein) against tumor cells to best target the cancer in people with pancreatic cancer. ...

Companies [2528 Associated Companies listed on BioPortfolio]

The Lustgarten Foundation for Pancreatic Cancer Research

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit support...

The Lustgarten Foundation

The Lustgarten Foundation, based in Bethpage, New York, is America's largest private foundation dedicated solely to funding pancreatic cancer research. Founded in 1998, the Foundation provides critica...

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organizat...

Pancreatic Cancer Action

About Pancreatic Cancer Action: 5 year survival rates for pancreatic cancer have not changed in over 40 years and it is our mission to change this by way of increased awareness of pancreatic cancer...

More Information about "The Lustgarten Foundation for Pancreatic Cancer Research" on BioPortfolio

We have published hundreds of The Lustgarten Foundation for Pancreatic Cancer Research news stories on BioPortfolio along with dozens of The Lustgarten Foundation for Pancreatic Cancer Research Clinical Trials and PubMed Articles about The Lustgarten Foundation for Pancreatic Cancer Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Lustgarten Foundation for Pancreatic Cancer Research Companies in our database. You can also find out about relevant The Lustgarten Foundation for Pancreatic Cancer Research Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record